TrueBinding: Funding, Investors & Team (Sep 2026)
TrueBinding is a startup that specializes in developing biotherapeutic molecules for treating diseases with high unmet medical needs, particularly in Immuno oncology. By utilizing the TruebindingTM platform, they have successfully identified 6 unknown ligands that specifically interact with checkpoint inhibitor pathways.
TrueBinding has raised $178M across 3 funding rounds on record, the most recent an undisclosed round of $57.7M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TrueBinding Company Profile and Key Stats
Latest funding round on record: Jul 2023.
TrueBinding Funding Rounds
TrueBinding raised $100M in an undisclosed round announced in Jul 2022.
8 months later, an undisclosed round of $20.0M was announced in Mar 2023.
4 months later, an undisclosed round of $57.7M was announced in Jul 2023.
TrueBinding Founders and Leadership Team
Contact details for the TrueBinding team: 1 of 2 have an email address on file.
Start 14-day free trial →TrueBinding Funding Compared to Other Biotechnology Startups
TrueBinding's latest round of $57.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TrueBinding in Biotechnology and Menlo Park
Companies Similar to TrueBinding
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
TrueBinding Funding FAQs
What does TrueBinding do?
TrueBinding is a startup that specializes in developing biotherapeutic molecules for treating diseases with high unmet medical needs, particularly in Immuno oncology. By utilizing the TruebindingTM platform, they have successfully identified 6 unknown ligands that specifically interact with checkpoint inhibitor pathways.
How much funding has TrueBinding raised?
TrueBinding has raised $178M across 3 rounds on record. The most recent is an undisclosed round of $57.7M announced in Jul 2023.
When did TrueBinding last raise funding?
TrueBinding's most recent funding round on record is an undisclosed round of $57.7M, announced in Jul 2023.
Who founded TrueBinding?
FundedIQ lists Akansha Mishra (Founder) at TrueBinding.
Who is the CEO of TrueBinding?
Dongxu Sun is listed as CEO at TrueBinding.
Where is TrueBinding headquartered?
TrueBinding is based in Menlo Park, California, United States.
How many employees does TrueBinding have?
TrueBinding is in the 101-250 employee band.
How does TrueBinding's funding compare to other Biotechnology startups?
TrueBinding's latest round of $57.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's TrueBinding Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TrueBinding is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.